Funded Tech Companies
Newleos Therapeutics
Headquartered in Boston, Newleos Therapeutics has funding from Arkin Bio-Ventures, Longwood Fund and DCVC Bio.
Company Overview
Company Name
Newleos Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
800 Boylston St. 1715
Boston, MA 02199
USA
Boston, MA 02199
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Our mission is to provide a new dawn or "eos" for patients suffering from a variety of mental health conditions by developing next generation, first- and best-in-class therapies.? Newleos Therapeutics is a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development. Newleos' clinical-stage pipeline was in-licensed from Roche and includes multiple oral small molecules targeting novel mechanisms across a broad range of indications, including generalized anxiety, social anxiety, substance use disorders, and cognitive impairment.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/13/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Donabedian
Company Investors
- Arkin Bio-Ventures
- Longwood Fund (David Donabedian)
- DCVC Bio
- Novo Holdings (Ray Camahort)
- Goldman Sachs (Ming Cheah)
Browse more funded tech companies:
NewLeaf Symbiotics | Newlight Technologies
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs